3-Amino-5-methylisoxazole → 1-{[5-(4-hydroxy-2H-1,2-benzothiazin-3-yl)-1,2,4-oxadiazol-3-yl]methyl}ethanone
反応式
[OH:1][C:2]1[C:7]2[CH:8]=[CH:9][CH:10]=[CH:11][C:6]=2[S:5](=O)(=O)[N:4](C)[C:3]=1[C:15](=[O:23])[NH:16][C:17]1[CH:21]=[C:20]([CH3:22])[O:19][N:18]=1.NC1C=C(C)ON=1.CC1ON=C(NC(=O)CN2C(=O)C3C=CC=CC=3S2(=O)=O)C=1>>[OH:1][C:2]1[C:7]2[CH:8]=[CH:9][CH:10]=[CH:11][C:6]=2[S:5][NH:4][C:3]=1[C:15]1[O:23][N:18]=[C:17]([CH2:21][C:20](=[O:19])[CH3:22])[N:16]=1参加物
実験手順
A novel process for preparing 4-hydroxy-3-(5-methyl-3-isoxazolylcarbamoyl)-2-methyl-2H-1,2-benzothiazine 1,1-dioxide (I), starting with 3-amino-5-methylisoxazole (II) is disclosed. Compound I exhibits anti-inflammatory properties and is useful for treating inflammation. In the process of the invention an intermediate obtained, 2,3-dihydro-N-(5-methyl-3-isoxazolyl)-3-oxo-1,2-benzisothiazole-2-actamide 1,1-dioxide (IV) undergoes rearrangement to provide 1-{[5-(4-hydroxy-2H-1,2-benzothiazin-3-yl)-1,2,4-oxadiazol-3-yl]methyl}ethanone, S,S-dioxide (V), which is methylated, according to conventional procedures. The methylated intermediate VI, upon further treatment, undergoes a second rearrangement to obtain the desired anti-inflammatory compound I.
後処理
- additionfor treating inflammation
- customIn the process of the invention an intermediate obtained
出典と根拠
- ORDレコード
- ord-3fc3b8d8200641638062677b92c0948f
- 出典データセット
- uspto-grants-1977_05
- 特許番号
- US04022796
反応ノート
読み込み中…